Achieve Clinical Research Announces Smoking Cessation Research Studies in Birmingham, Alabama

Birmingham, Alabama, January 10, 2011 — Achieve Clinical Research, a privately owned research facility, founded in 1998 in Birmingham, Alabama, announces the launch of several research studies to test investigational treatment options for those already diagnosed with nicotine addiction. “Through smoking cessation clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with nicotine addiction,” says Hayes Williams, MD, PhD., the Medical Director and Principal Investigator at Achieve Clinical Research since 2001. “Treatments for smoking cessation are one of the research studies we are pleased to continue with at Achieve Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans.”

The research studies will enroll those already diagnosed with nicotine addiction, which includes symptoms like intense cravings for a cigarette when stressed, and anxiety, agitation, headaches, and nausea when without a cigarette for more than thirty minutes. In order to participate in the studies volunteers must be diagnosed with nicotine addiction. Achieve Clinical Research will not take volunteers who:

  • have any evidence or treatment of malignancy within the previous 5 years,
  • have a history of alcohol or substance abuse within the previous 5 years,
  • have used an investigatory drug or participated in an investigatory study within 30 days of the screening,
  • are pregnant, or
  • are breast-feeding.

Achieve Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. For more information regarding participation in our research studies, contact Achieve Clinical Research at 205.380.6443, or at



Submit form to get started

Recent Posts